Tamer Sağıroğlu1, Serhat Oğuz1, Gönül Sağıroğlu2, Elif Copuroğlu2, Tulin Yalta3, Mustafa Burak Sayhan4, Mehmet Ali Yağcı5. 1. Department of General Surgery, Faculty of Medicine, Trakya University, Edirne, Turkey. 2. Department of Anesthesiology and Reanimation, Faculty of Medicine, Trakya University, Edirne, Turkey. 3. Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey. 4. Department of Emergency, Faculty of Medicine, Trakya University, Edirne, Turkey. 5. Department of General Surgery, Hakkari Goverment Hospital, Hakkari, Turkey.
Abstract
OBJECTIVE: Intestinal ischemia-reperfusion (I/R) injury is associated with high morbidity and mortality rates. There is ongoing research to find an effective preventive or treatment agent. We aimed to evaluate the effects of apelin 13 (AP) on intestinal I/R injury in a rat model. MATERIAL AND METHODS: Twenty-four male Sprague-Dawley rats aged 6-8 weeks and weighing 280±20 g were equally divided into three groups (control, I/R and I/R+AP). The control group underwent superior mesenteric artery (SMA) mobilization alone without any clamping. In the I/R and I/R+AP groups, an atraumatic microvascular bulldog clamp was placed across the SMA at its point of origin from the aorta. In the I/R+AP group, 2 μg/kg/d apelin was administered intraperitoneally. After 60 minutes of ischemia, relaparotomy was performed to remove the microvascular clamp on the SMA for 3 hours of reperfusion. After 3 hours, tissue samples were obtained for biochemical [malondialdehyde (MDA) and glutathione (GSH) levels] and histopathological analyses. RESULTS: MDA levels were significantly higher in the I/R group compared to the control group. Although MDA levels were lower in the I/R+AP group compared tothe I/R group, the difference was not statistically significant. There was also no significant difference between the I/R+AP and I/R groups regarding GSH levels. The median histopathological grade was significantly lower in the I/R+AP group compared to the I/R group (p=0.001). CONCLUSION: Apelin appeared to have a positive effect on oxidative injury; this did not reach statistical significance. Thus, the role of apelin and associated findings in the initial treatment of intestinal ischemia needs further large-scale animal studies before human use.
OBJECTIVE:Intestinal ischemia-reperfusion (I/R) injury is associated with high morbidity and mortality rates. There is ongoing research to find an effective preventive or treatment agent. We aimed to evaluate the effects of apelin 13 (AP) on intestinal I/R injury in a rat model. MATERIAL AND METHODS: Twenty-four male Sprague-Dawley rats aged 6-8 weeks and weighing 280±20 g were equally divided into three groups (control, I/R and I/R+AP). The control group underwent superior mesenteric artery (SMA) mobilization alone without any clamping. In the I/R and I/R+AP groups, an atraumatic microvascular bulldog clamp was placed across the SMA at its point of origin from the aorta. In the I/R+AP group, 2 μg/kg/d apelin was administered intraperitoneally. After 60 minutes of ischemia, relaparotomy was performed to remove the microvascular clamp on the SMA for 3 hours of reperfusion. After 3 hours, tissue samples were obtained for biochemical [malondialdehyde (MDA) and glutathione (GSH) levels] and histopathological analyses. RESULTS:MDA levels were significantly higher in the I/R group compared to the control group. Although MDA levels were lower in the I/R+AP group compared tothe I/R group, the difference was not statistically significant. There was also no significant difference between the I/R+AP and I/R groups regarding GSH levels. The median histopathological grade was significantly lower in the I/R+AP group compared to the I/R group (p=0.001). CONCLUSION: Apelin appeared to have a positive effect on oxidative injury; this did not reach statistical significance. Thus, the role of apelin and associated findings in the initial treatment of intestinal ischemia needs further large-scale animal studies before human use.
Authors: Jimie Anderson; Sherry D Fleming; Scott Rehrig; George C Tsokos; Milan Basta; Terez Shea-Donohue Journal: Clin Immunol Date: 2005-02 Impact factor: 3.969
Authors: James C Simpkin; Derek M Yellon; Sean M Davidson; Shiang Y Lim; Abigail M Wynne; Christopher C T Smith Journal: Basic Res Cardiol Date: 2007-08-13 Impact factor: 17.165
Authors: Michelle Duggan; Doreen Engelberts; Robert P Jankov; Jordan M A Worrall; Rong Qu; Gregory M T Hare; A Keith Tanswell; J Brendan Mullen; Brian P Kavanagh Journal: Can J Anaesth Date: 2005-03 Impact factor: 5.063
Authors: Mustafa B Sayhan; Serhat Oguz; Ömer Salt; Nuray Can; Taner Ozgurtas; Tulın D Yalta Journal: Arch Med Sci Date: 2018-12-10 Impact factor: 3.318